Chancellor Rachel Reeves Plans Specific Measures on Household Expenses in Upcoming Budget
Chancellor Reeves has announced she is preparing "focused action to deal with cost of living pressures" in the upcoming Budget.
In comments to media outlets, she noted that lowering price rises is a collective task of both the administration and the central bank.
The UK's inflation rate is expected to be the highest among the Group of Seven advanced economies this year and next.
Potential Utility Cost Interventions
Reports indicate the administration could take action to reduce energy bills, for example by slashing the present 5% rate of VAT applied on energy supplies.
An additional possibility is to lower some of the regulatory levies presently added to bills.
Fiscal Constraints and Expert Expectations
The government will receive the latest draft from the official forecaster, the Office for Budget Responsibility, on Monday, which will reveal how much room there is for these actions.
The expectation from the majority of analysts is that Reeves will have to introduce tax increases or budget cuts in order to meet her self-imposed borrowing rules.
Previously on the same day, estimates showed there was a £22bn deficit for the chancellor to fill, which is at the lower end of expectations.
"There's a shared responsibility between the central bank and the administration to further reduce some of the causes of price increases," the Chancellor informed reporters in Washington, at the conferences of the IMF and global financial institution.
Tax Commitments and Global Issues
While much of the attention has been on expected tax rises, the chancellor said the latest figures from the fiscal watchdog had not altered her pledge to campaign commitments not to increase rates on earnings tax, sales tax or social security contributions.
She blamed an "uncertain global environment" with increasing geopolitical and trade tensions for the fiscal tax moves, likely to be directed on those "with the broadest shoulders."
International Economic Tensions
Addressing apprehensions about the United Kingdom's trade ties with China she said: "The UK's national security invariably take priority."
Recent announcement by China to increase trade restrictions on critical minerals and other resources that are essential for high-technology production led American leader Donald Trump to threaten an extra 100% tariff on goods from the Asian country, raising the risk of an full-scale trade war between the two economic giants.
The American finance chief described the Chinese action "economic coercion" and "a international production control attempt."
Questioned on considering the US offer to join its dispute with China, the Chancellor said she was "extremely troubled" by Chinese actions and called on the Beijing authorities "not to put up barriers and limit trade."
She said the move was "harmful for the world economy and causes additional challenges."
"It is my opinion there are sectors where we need to challenge China, but there are also valuable prospects to sell into China's economy, including financial services and other sectors of the economy. We've got to maintain that balance correct."
The chancellor also confirmed she was collaborating with G7 counterparts "on our own critical minerals approach, so that we are less reliant."
Health Service Drug Costs and Funding
The Chancellor also acknowledged that the cost the National Health Service pays for medicines could go up as a consequence of ongoing negotiations with the US government and its pharmaceutical firms, in return for reduced taxes and capital.
A number of the biggest global pharmaceutical manufacturers have said recently that they are either pausing or scrapping investments in the UK, with several blaming the modest returns they are getting.
Recently, the government science advisor said the cost the health service pays for medicines would need to increase to halt firms and pharmaceutical investment leaving the UK.
Reeves stated to the BBC: "It has been observed due to the payment system, that medical research, recent pharmaceuticals have not been offered in the United Kingdom in the way that they are in other European countries."
"The objective is to make sure that people getting care from the NHS are able to obtain the finest critical treatments in the globe. And so we are looking at this situation, and... seeking to secure increased funding into the UK."